Antibody detection method based on organic electrochemical transistor

By using an antibody sensor based on organic electrochemical transistors, the problems of low detection rate and insufficient discrimination ability in schistosomiasis detection have been solved, achieving rapid and accurate antibody detection, especially with significant advantages in the detection of low concentrations and different types of antibodies.

CN119044283AActive Publication Date: 2024-11-29JIANGNAN UNIV +1
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
CN202411128006.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-16
Publication Date
2024-11-29
Estimated Expiration
2044-08-16

AI Technical Summary

Technical Problem

Existing methods for detecting schistosomiasis have problems such as low detection rate, long detection time, and inability to quickly distinguish between different types of antibodies, making accurate diagnosis particularly difficult in acute and chronic infections.

Method used

An antibody sensor based on an organic electrochemical transistor is used. By modifying the organic semiconductor layer and the gate surface to form a self-assembled molecular membrane, the schistosomiasis antibody is detected by current change. Quantitative analysis is performed by combining phosphate buffer and serum samples. The detection conditions are optimized to improve specificity and sensitivity.

Benefits of technology

It enables rapid and accurate detection of schistosomiasis antibodies, can confirm infection within 10 days, and can differentiate between liver flukes and lung flukes. It has high sensitivity and specificity and is suitable for clinical diagnosis, biological research and food safety monitoring.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119044283A_ABST
    Figure CN119044283A_ABST
Patent Text Reader

Abstract

The invention discloses an antibody detection method based on an organic electrochemical transistor, and belongs to the technical field of biosensing and antibody detection. A novel organic electrochemical transistor is prepared for antibody detection research, and the main content and conclusion are as follows: the preparation of the organic electrochemical transistor is completed through the steps of spin coating, annealing, evaporation and the like, and then a schistosome antigen is fixed on the surface of the sensor. Functional characterization is carried out through a semiconductor parameter analyzer, a scanning electron microscope, an atomic force microscope and the like. The current variation in the organic electrochemical transistor is gradually increased along with continuous binding of the antibody with the modified antigen in PBS and serum, so that a standard curve is drawn, and the condition of schistosome infection can be quantitatively detected. Experimental results show that the device can detect the schistosome antibody as low as 0.001 [mu] g / mL, and the sensitivity is high. Compared with a commercially available test strip, the sensitivity and the specificity of the sensor are greatly improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to an antibody detection method based on an organic electrochemical transistor, and belongs to the technical field of biosensing and antibody detection. Background Art

[0002] The detection method of schistosomiasis is a complex and delicate process involving multiple levels to ensure the accuracy and reliability of diagnosis. In terms of etiological diagnosis, the direct smear method is suitable for heavily infected areas. It observes the eggs in the feces of patients or the mucus and bloody stool of acute schistosomiasis patients under a microscope, but this method is limited by the sample quality and the uniformity of the egg distribution, so the egg detection rate is relatively low. In order to improve the positive detection rate, the miracidium hatching method is widely used. It hatches the eggs under suitable conditions so that the miracidium can be hatched and easier to detect. However, this method takes a certain amount of time, usually from several hours to several days, so it is not suitable for urgent diagnosis. The quantitative transparency rule provides a more accurate method for counting eggs. By using a microscope to observe and count, the degree of infection can be quantitatively assessed. For patients with chronic and advanced schistosomiasis, due to the thickening of the intestinal wall tissue, the discharge of eggs is blocked. At this time, rectal mucosal biopsy is very important. Observing the intestinal mucosal lesions through a rectal microscope can more accurately judge the condition.

[0003] In terms of immunological diagnosis, intradermal testing is a commonly used screening method. It observes skin reactions by injecting antigens, and has a high consistency rate with positive stool egg tests. However, false positive or false negative reactions may also occur, so a comprehensive judgment needs to be made in combination with other test results.

[0004] Purified antigens and recombinant antigens can be used to diagnose schistosomiasis due to their high sensitivity and specificity. Detecting antibodies is a more sensitive and specific method. By detecting specific antibodies in serum such as IgM, IgG, IgE, etc., the infection situation can be indirectly inferred. If the subject has not been treated for the pathogen and the specific antibody is positive, it is of great significance to determine the diagnosis. Circulating antigen enzyme immunoassay is another important immunological examination method. By detecting circulating antigens, it provides a strong basis for the diagnosis of schistosomiasis. Wang Bolan et al.'s research showed that TRFIA and DDIA have higher detection rates than ELISA in detecting late, acute and chronic schistosomiasis. Yang Hui et al.'s research showed that the sensitivity can be increased to 99.3% when ELISA is tested together with DDIA and DIGFA. In addition to etiological and immunological diagnosis, other examination methods also play an auxiliary role in the diagnosis of schistosomiasis. Using probes to detect schistosome antibodies can provide another angle for the detection of schistosomes. Blood examination can reflect the changes in peripheral blood of patients with schistosomiasis in the acute phase, such as a significant increase in eosinophils.

[0005] Liver function tests can assess liver damage. In acute patients, serum globulin is elevated, serum ALT and AST are slightly elevated, and in late-stage patients, albumin is reduced and globulin is elevated. Imaging tests such as B-ultrasound and CT scans can visually display the location, range and extent of the lesions, providing important reference information for doctors.

[0006] In summary, there are many ways to detect schistosomiasis. Doctors will choose the appropriate test method for diagnosis based on the patient's specific situation and clinical manifestations. At the same time, with the continuous advancement of medical technology, new detection methods are constantly emerging, providing a broader space for the diagnosis and treatment of schistosomiasis.

[0007] The technology of organic electrochemical transistors has made great progress in antigen-antibody research. Studies have shown that the use of pH-sensitive organic electrochemical transistors is expected to realize the in-situ application of wearable electronic devices in physiological monitoring, showing broad application prospects. The flexible organic electrochemical transistor designed by Liu Jian has improved the detection ability of H2O2. Chen Lizhen and others have achieved qualitative measurement of cell surface polysaccharides using organic electrochemical transistors. Feng Xiaoqian and his team have made a detailed explanation of organic electrochemical transistor biosensors in the fields of biological detection such as glucose, DNA, antibody antigens, cells, and dopamine, focusing on their sensing mechanisms and detection performance. OECT has shown broad application prospects in the fields of biosensing, environmental monitoring, and medical diagnosis, and is expected to play an important role in emerging fields such as flexible electronic skin and smart wearable devices.

[0008] In summary, the research on OECT is constantly making new progress, and its application prospects in the field of sensing are broad. Summary of the invention

[0009] (1) Based on the research on organic electrochemical transistors at home and abroad, we will find suitable methods to modify organic electrochemical transistors and prepare for subsequent experiments.

[0010] (2) Probe modification: antibodies can bind to antigen epitopes through non-covalent interactions. Using a surface grafting strategy, schistosome egg antigens are bound to the surface of the detection area, and the modification effect is evaluated by current changes, Raman, scanning electron microscopy, etc.

[0011] (3) The obtained data were plotted and the relationship between the current response and the concentration of the analyte was studied by detecting different concentrations of schistosome antibodies in phosphate buffer. Based on the results, the binding temperature, incubation time and other conditions were optimized to explore the detection performance of the sensor. Based on the results of multiple experiments, a standard curve was established to calculate key indicators such as the detection limit and sensitivity.

[0012] (4) Serum testing was performed by preparing serum samples containing different concentrations of antibodies and detecting them using the antigen-modified sensor. The actual performance of the sensor was analyzed and compared with the standard method.

[0013] (5) Specificity analysis was performed, and control experiments were carried out using liver fluke and lung fluke antibodies as interferences to verify the specificity of the sensor and compare it with the standard method.

[0014] This project uses Schistosoma japonicum antibodies as a model, modifies the egg antigens on the surface of semiconductor sensors, and achieves quantitative detection of antibodies by measuring current changes. This method does not require the introduction of markers, and the detection mode is direct. Other biological molecules can be detected by replacing the probe, so it has potential application prospects and is expected to provide new ideas for food contaminant detection.

[0015] The present invention provides an antibody sensor based on an organic electrochemical transistor, wherein the device comprises, from bottom to top, a substrate layer, an organic semiconductor layer, a solid ion gel electrolyte layer, an organic semiconductor doping layer and a gate; the organic semiconductor layer and the organic semiconductor doping layer are both P-type organic semiconductors, and the organic semiconductor doping layer is a P-type organic semiconductor doped with a P-type dopant;

[0016] After the gate surface is cleaned with ethanol and water, cysteamine and soluble insect egg antigen SEA are used as modifiers in sequence to modify the gate surface of the device to form a self-assembled molecular film.

[0017] In one embodiment of the present invention, the substrate layer is: a glass sheet or a polyimide substrate of the source and drain electrodes;

[0018] In one embodiment of the present invention, the solid ion gel electrolyte layer is formed by spin coating after doping ion liquid into PVDF-HFP solution;

[0019] In one embodiment of the present invention, the ionic liquid is EMIM TFSI, EMIM BF4 or a mixture thereof.

[0020] In one embodiment of the present invention, the method for modifying the gate self-assembled molecular film comprises:

[0021] (1) Wash with water and ethanol respectively and then blow dry;

[0022] (2) After drying, add cysteamine to the gate and react for 6 to 8 hours in the dark. After washing with water and drying, add glutaraldehyde and react for 1 to 2 hours.

[0023] (3) After the reaction in step (2), the grid is rinsed with water and blown dry, and soluble egg antigen SEA is added to react again for 1 to 2 hours;

[0024] (4) After the reaction in step (3) is completed, the mixture is rinsed and dried, and then bovine serum albumin is added to react for 1 to 2 hours to passivate the aldehyde groups that have not reacted with SEA, followed by washing and drying.

[0025] In one embodiment of the present invention, in step (2), the concentration of cysteamine is 0.4-0.5 mM.

[0026] In one embodiment of the present invention, the volume fraction of glutaraldehyde is: 2 to 2.5%;

[0027] In one embodiment of the present invention, the concentration of the soluble egg antigen SEA in step (3) is: 45-50 μg / mL;

[0028] In one embodiment of the present invention, the mass fraction of bovine serum albumin in step (4) is 1 to 1.5%.

[0029] The present invention also provides a method for preparing an antibody sensor based on an organic electrochemical transistor, the method comprising:

[0030] Step 1): spin coating a layer of organic semiconductor solution on the substrate with the active and drain electrodes, and annealing to form an organic semiconductor layer;

[0031] Step 2): spin coating an ionic gel electrolyte solution on the organic semiconductor layer, and heating and curing the solution to form a solid ionic gel electrolyte layer;

[0032] Step 3): spin coating a mixed solution of an organic semiconductor and a dopant on the solid ion gel electrolyte layer, and annealing to form an organic semiconductor doping layer;

[0033] Step 4): evaporating a gate electrode on the organic semiconductor doping layer;

[0034] Step 5): After the gate surface is washed with ethanol and water, cysteamine and soluble egg antigen SEA are used as modifiers in sequence to modify the gate surface of the device to form a self-assembled molecular film.

[0035] In one embodiment of the present invention, the organic semiconductor in step 1) and the organic semiconductor in step 3) are P-type organic semiconductors.

[0036] In one embodiment of the present invention, the ionic colloid electrolyte solution is a PVDF-HFP solution doped with an ionic liquid.

[0037] In one embodiment of the present invention, the ionic liquid is EMIM TFSI, EMIM BF4 or a mixture thereof.

[0038] In one embodiment of the present invention, the dopant in step 3) is a P-type dopant;

[0039] In one embodiment of the present invention, the method for modifying the gate self-assembled molecular film comprises:

[0040] (1) Wash with water and ethanol respectively and then blow dry;

[0041] (2) After drying, add cysteamine to the gate and react for 6 to 8 hours in the dark. After washing with water and drying, add glutaraldehyde and react for 1 to 2 hours.

[0042] (3) After the reaction in step (2), the grid is rinsed with water and blown dry, and soluble egg antigen SEA is added to react again for 1 to 2 hours;

[0043] (4) After the reaction in step (3) is completed, the mixture is rinsed and dried, and then bovine serum albumin is added to react for 1 to 2 hours to passivate the aldehyde groups that have not reacted with SEA, followed by washing and drying.

[0044] The present invention also provides a method for detecting SEA antibodies in a sample, which is not for the purpose of disease diagnosis and treatment. The method is to add the sample to the gate of the above-mentioned antibody sensor based on organic electrochemical transistor for reaction, and then detect whether the sample contains SEA antibodies through the current-voltage curve, and at the same time detect the content of SEA antibodies in the sample.

[0045] In one embodiment of the present invention, the sample is a body fluid sample.

[0046] In one embodiment of the present invention, the body fluid is selected from any one of saliva, tissue fluid, blood, PBS buffer, and sweat.

[0047] In one embodiment of the present invention, after the sample is added to the gate, the voltage between the source and the drain is adjusted to 1V, and the gate voltage is -3V to +3V.

[0048] In one embodiment of the present invention, when the gate voltage is fixed at -3 V and the sample is a buffer solution, the content of SEA antibody in the sample is detected by the following formula: y = -0.0085x4 + 0.0978x3 - 0.3255x2 + 0.4524x - 0.0417;

[0049] In one embodiment of the present invention, the gate voltage is fixed to -3 V, and when the sample is serum, the content of SEA antibodies in the sample is detected by the following formula: y = -0.0016x4 + 0.0205x3 - 0.0918x2 + 0.2061x - 0.0592.

[0050] The present invention provides a product, which contains the above-mentioned antibody sensor based on organic electrochemical transistor; the product is a biochip for detecting SEA antibodies in a sample, or the product is a device for detecting SEA antibodies in a sample, or the product is a kit for detecting SEA antibodies in a sample.

[0051] In one embodiment of the present invention, the product is used to detect SEA antibodies in a sample; the detection method is the same as above.

[0052] The present invention also provides the use of the above-mentioned antibody sensor in the preparation of a product for detecting SEA antibodies in a sample, wherein the product is a biochip for detecting SEA antibodies in a sample, or the product is a device for detecting SEA antibodies in a sample, or the product is a kit for detecting SEA antibodies in a sample.

[0053] Beneficial Effects

[0054] 1. We designed and prepared a surface functionalized organic electrochemical transistor (OECT) device. By adjusting the voltage of the source, drain and gate electrodes and measuring the current-voltage curve, we proved its reliability and stability.

[0055] 2. Phosphate buffered saline (PBS) and rabbit serum were used as antibody solvents to draw a detection standard curve, achieving quantitative detection of SEA antibodies. This result shows that OECT devices are not only suitable for antibody detection under different solvent conditions, but also have high accuracy and repeatability.

[0056] 3. Compared with the commercially available schistosomiasis infection detection test strips, the OECT device designed in this experiment showed extremely high sensitivity and specificity. It can detect schistosomiasis antibodies as low as 0.001μg / mL, and the current change is significantly higher than the antibodies that the other two test strips cannot distinguish (liver fluke and lung fluke antibodies). This feature gives the OECT device a significant advantage in the field of antibody detection, especially in rapid detection scenarios that require distinguishing different types of antibodies or detecting low-concentration antibodies.

[0057] 4. Based on the high sensitivity and specificity of OECT devices in antibody detection, we can foresee that it has broad application prospects in clinical diagnosis, biological research, food safety monitoring and other fields. For example, in the medical field, OECT devices can be used to quickly and accurately detect antibodies of various pathogens, providing strong support for early diagnosis and prevention of diseases; in the field of biological research, it can be used to study the interaction and signal transduction mechanism between biological molecules; in the field of food safety monitoring, it can be used to detect harmful substances and pollutants in food. Although the current OECT device has shown good detection performance, we can still further improve its performance by optimizing detection conditions, optimizing device structure, and improving material selection.

[0058] 5. The OECT device designed in this experiment showed extremely high sensitivity and specificity. It was able to detect schistosome antibodies as low as 0.001 μg / mL, and could achieve early detection of schistosome infection (can be diagnosed within 10 days). However, the specificity analysis of existing schistosome detection kits on the market showed that it could not be detected below 2 mg / mL, resulting in patients often having to wait for about one month after infection for the number of antibodies in the body to reach a certain concentration before being diagnosed, thus delaying the best period for diagnosis and treatment. It can be seen that the detection method of the present invention shortens the infection time of patients, and the current detectable infection time has been advanced from one month (test strip) to within 10 days.

[0059] Furthermore, the test strips currently used cannot distinguish between liver flukes and lung flukes, but the sensor of the present invention can achieve quantitative and qualitative distinction between liver flukes and lung flukes. BRIEF DESCRIPTION OF THE DRAWINGS

[0060] Figure 1 : Structural diagram and physical picture of organic electrochemical transistor.

[0061] Figure 2 : Stability detection of OECT devices; (a) is the unidirectional scanning IV curve of the OECT device, and (b) is the transfer characteristic curve.

[0062] Figure 3 : Diagram of the surface functionalization process of OECT devices.

[0063] Figure 4 : Electron microscopy observation of the modified area of ​​the organic electrochemical transistor before and after SEA modification; a) electron microscopy image before modification, (b) electron microscopy image after modification.

[0064] Figure 5 : Atomic force microscopy (AFM) observation results of the modified area of ​​the organic electrochemical transistor before and after SEA modification, (a) AFM image 3D characterization before modification and (b) 3D characterization after modification.

[0065] Figure 6 :(a) Bidirectional scanning IV curve before and after modification and (b) current change bar graph before and after modification.

[0066] Figure 7 : (a) Current-voltage curve and (b) current-time curve.

[0067] Figure 8 : Standard curve of current change and anti-SEA concentration in PBS system.

[0068] Fig. 9 :Standard curve of current change and anti-SEA concentration in rabbit serum system

[0069] Fig.10 : Current changes of three antibodies at concentrations of (a) 0.1 μg / mL, (b) 1 μg / mL, and (c) 10 μg / mL.

[0070] Fig.11 :Test results of the kit: (a) Schistosoma japonicum antibody, (b) liver fluke antibody, (c) lung fluke antibody. DETAILED DESCRIPTION

[0071] In the present invention, the gate is attached Figure 1 The modifiers in the formula are different expressions of the same substance.

[0072] The ethanol involved in the following examples was purchased from Sinopharm Chemical Reagent Co., Ltd., phosphate buffer (PBS) was purchased from Aladdin Chemical Co., Ltd., Shanghai, China, cysteamine (Cys) was purchased from Aladdin Chemical Co., Ltd., Shanghai, China, glutaraldehyde was purchased from China Pharmaceutical Chemical Reagent Co., Ltd., soluble egg antigen SEA, schistosome antibody anti-(SEA), rabbit serum, liver fluke antibody, lung fluke antibody were provided by Jiangsu Schistosoma Control Institute, bovine serum albumin (BSA) was purchased from Aladdin Chemical Co., Ltd., Shanghai, China, and BCA kit was purchased from Anhui White Shark Biotechnology Co., Ltd.

[0073] The detection method involved in the following embodiments

[0074] Determination of antigen-antibody concentration

[0075] In this experiment, schistosome antigen-antibody, liver fluke antigen-antibody, and lung fluke antigen-antibody were provided by Jiangsu Schistosoma Control Institute. The antigen-antibody samples were used to prepare a standard curve using the White Shark BCA kit, and the concentration was measured by comparing the standard curve. The samples were then diluted to the required concentration in preparation for subsequent experiments.

[0076] Measuring characterization of OECT devices

[0077] It is mainly carried out using electron microscope, atomic force microscope and kickstart2 semiconductor analyzer.

[0078] The surface morphology of the device was observed using a scanning electron microscope (SEM) to obtain the surface morphology characteristics and electrode structure of the device. The acceleration voltage and probe current were adjusted to obtain a high-resolution surface morphology image. Next, a transmission electron microscope was used to observe the internal structure of the device to explore the microstructure and interface characteristics of the organic semiconductor layer.

[0079] The OECT device was characterized using an atomic force microscope (AFM) to obtain the morphology and nanoscale surface features of the device surface. By adjusting the position and vibration frequency of the probe, high-resolution surface topology images and surface roughness information can be obtained.

[0080] The electrical properties of OECT devices were measured and analyzed using a kickstart2 semiconductor parameter analyzer.

[0081] Place the device in the test fixture, place the probes on the designated source, gate, and drain electrodes, and connect to the computer for analysis. Then, by setting appropriate test parameters such as voltage range, scan rate, scan points, and scan time, conduct electrical performance tests, including output characteristics, current-voltage curves, current-time curves, etc.

[0082] The invention provides a low operating voltage electrochemical transistor, which is an electrochemical transistor using Cr / Au:5nm / 50nm electrodes as source and drain electrodes, P3HT as an organic semiconductor layer, PVDF-HFP mixed EMIM TFSI ion gel as a solid ion gel electrolyte layer, TrTPFB and PBBT-2T mixed solution as an organic semiconductor doping layer and gold as a gate.

[0083] The present invention provides an antibody sensor based on an organic electrochemical transistor. The device comprises, from bottom to top, a substrate layer, a semiconductor layer, an ion glue layer, a doping layer and a gate. After the surface of the gate is cleaned with ethanol and water, cysteamine and a soluble insect egg antigen SEA are used as modifiers in sequence to modify the surface of the device gate to form a self-assembled molecular film.

[0084] Example 1: OECT device preparation

[0085] (1) A glass substrate with chromium-gold (Cr / Au: 5nm / 50nm) source and drain electrodes was ultrasonically cleaned for 2 min using deionized water, acetone, and isopropanol in sequence, and then dried using an argon gun.

[0086] (2) transferring the source and drain electrode glass substrate cleaned in step (1) into an ozone treatment device for 15 minutes to change the wettability of the substrate surface, which is beneficial for subsequent thin film deposition;

[0087] (3) Preparation of semiconductor P3HT solution: In a glove box filled with argon, P3HT was dissolved in chlorobenzene at a concentration of 5 g / L and heated at 50°C for 1 h to dissolve. Excess impurities were removed using a PTFE filter with a pore size of 0.45 μm.

[0088] (4) Spin coating the prepared semiconductor P3HT solution on the glass substrate treated in step (2), setting the spin coating speed to 1500 rpm, the time to 30 s, and the annealing process to heat at 130° C. for 5 min to form an organic semiconductor layer.

[0089] (5) Preparation of ionic gel electrolyte layer solution: PVDF-HFP was dissolved in 2-butanone at a concentration of 100 g / L. Then, the ionic liquid (EMIM TFSI) was added to the PVDF-HFP solution at a volume ratio of 1%. The solution was then heated on a hot plate at 60°C and stirred at 200 rpm overnight. A uniform ionic gel electrolyte solution was obtained after the solution was fully dissolved.

[0090] The prepared gel electrolyte layer solution is spin-coated on the organic semiconductor layer obtained in step (4). Before spin coating, it needs to be preheated at 60°C and stirred at 200 rpm for 10 minutes to prevent solute separation. The spin coating speed is 2000 rpm and the time is 30 seconds. After the spin coating is completed, the organic semiconductor layer is immediately transferred to a hot plate for heating at 90°C for 2 hours to form a dense and highly elastic solid ion gel layer.

[0091] (6) preparing an organic semiconductor solution and a dopant solution respectively: in a glove box filled with argon, dissolving PBBT-2T and TrTPFB in chlorobenzene at a concentration of 5 g / l, heating at 50° C. for 1 h to dissolve, and removing excess impurities with a PTFE filter with a pore size of 0.45 μm to prepare an organic semiconductor solution and a dopant solution respectively;

[0092] Preparation of a mixed solution of an organic semiconductor and a dopant: The dopant solution and the organic semiconductor solution are mixed in a molar ratio of TrTPFB to PBBT-2T monomers of 6:10, and the mixture is ready for use without heating or filtering;

[0093] The prepared mixed solution of organic semiconductor and dopant is spin-coated on the solid ion gel electrolyte layer at a rotation speed of 1500 rpm for 30 seconds. The annealing process is heating at 90° C. for 20 minutes to form an organic semiconductor doping layer.

[0094] (7) 50 nm Au was deposited on the organic semiconductor doping layer through a mask as a gate electrode ( Figure 1 A low operating voltage electrochemical transistor device can be obtained.

[0095] Preferably, Figure 1 The right side of the picture is the actual picture.

[0096] The results show:

[0097] Figure 1On the left side of the middle is the structure diagram of the OECT device. Through the structure diagram, you can see the arrangement and connection between the layers inside the device. In particular, the distribution and configuration of doping layers, ion glue, and P3HT- and other materials are key factors affecting the performance of OECT devices. The doping layer is used to control the flow of current, and its structure and material selection have an important influence on the conductive properties of the device. The ion glue is used as an adhesive to fix and connect the layers, and its quality and stability are directly related to the reliability and life of the device. Organic materials such as P3HT- may bring specific electrical or optical properties to the device.

[0098] Figure 1 On the middle right is a physical picture of the OECT device. It can be observed from the figure that the device has a clear source, drain and gate, which are the basic components of the OECT. The channel part between the source and drain is the key area of ​​the organic electrochemical transistor. Its morphology and structure have an important influence on the performance of the device. In addition, there are multiple metal contact points on the OECT device. These contact points are used to connect to the external circuit to realize the input and output of current. The reasonable location and layout of these contact points not only ensure the smooth transmission of current, but also avoid possible short circuit or leakage problems.

[0099] Example 2: Characterization of OECT devices

[0100] The electrical properties of OECT devices were measured and analyzed using the Kickstart2 semiconductor parameter analyzer:

[0101] Place the device in the test fixture, place the probes on the designated source, gate, and drain electrodes, and connect to the computer for analysis. Then, by setting appropriate test parameters such as voltage range, scan rate, scan points, and scan time, conduct electrical performance tests, including output characteristics, current-voltage curves, current-time curves, etc.

[0102] In this embodiment, the source voltage is set to 1V, the drain voltage is set to 1V, the gate voltage is set to -3V, -2V, -1V, 0V, 1V, 2V or 3V, and the current-voltage curve of the device is measured. The test data is processed and analyzed using origin to obtain the key device parameters of the device, such as the current change before and after the device is modified.

[0103] The results show:

[0104] (1) To prove the stability of the OECT device, we tested the IV curve of the device when the voltage between the source and drain electrodes was 1V and the gate voltage varied from -3V to +3V. The results are shown in Figure 2. Figure 2 As shown in (a);

[0105] (2) Figure 2(b) in the figure is the transfer characteristic curve of the OECT device. For the prepared organic electrochemical transistor, by controlling the scanning voltage between the source and the drain to 0-1V, the gate voltage is changed to -3V, -2V, -1V, 0V, 1V, 2V, and 3V respectively, and the current variation curve of the device over time is measured. It is observed that as the gate voltage continues to increase, the current continues to decrease.

[0106] The phenomenon that the current of OECT decreases with increasing gate voltage may be due to the regulatory effect of gate voltage on channel conductivity and source-drain current, as well as the combined effect of factors such as interface effect and charge accumulation.

[0107] Example 3: OECT probe modification

[0108] The present invention performs probe modification on the prepared OECT, wherein: Figure 3 This is the schematic diagram of the modification process; specifically: first, one end of cysteamine is a thiol (-SH), which reacts with the hydroxyl group on the device surface under strong interaction force to bind to the gate surface. The amino group (-NH2) at the other end of cysteamine reacts with the aldehyde group (-CHO) of glutaraldehyde to connect glutaraldehyde to the device through a carbon-nitrogen bond, and then the amino group of SEA reacts with the other end of glutaraldehyde to bind together, and finally the unbound aldehyde group of BSA is passivated. Then the modified OECT device is obtained, which is subsequently used to bind anti-SEA for measurement.

[0109] The specific steps are as follows:

[0110] (1) The OECT device prepared in Example 1 was taken out, cleaned with distilled water and anhydrous ethanol for 5-10 min respectively, and dried in a fume hood.

[0111] (2) After drying, add 20 μL of 0.5 mM cysteamine to the gate ( Figure 1 The modified grid was placed in a refrigerator and kept away from light for 6.5 hours. The unreacted cysteamine on the surface was then washed with ultrapure water, dried, and 10 μL of 2.5% glutaraldehyde was added and reacted for 2 hours.

[0112] (3) After the reaction in step (2), rinse the gate with ultrapure water ( Figure 1 The modified grid was removed and blown dry, and 10 μL of 50 μg / mL soluble egg antigen SEA was added to react again for 2 h.

[0113] (4) After the reaction in step (3) is completed, rinse with PBS solution 2-3 times to prevent unreacted SEA from remaining. After blowing the electrode dry, add 10 μL of 1% (v / v) bovine serum albumin (BSA) to passivate the aldehyde groups that have not reacted with SEA. After 1 hour, rinse with ultrapure water and dry the electrode, seal it with a vacuum sealer and store it in a -4°C refrigerator for use.

[0114] Example 4: OECT probe characterization

[0115] After the device was modified, SEA antigen was bound to the surface of the OECT device, and the device was characterized again by electron microscopy, atomic force microscopy and kickstart2 semiconductor analyzer.

[0116] The surface morphology of the device was observed by SEM, with special attention paid to the morphology and distribution of the antigen binding region. The parameters were adjusted to obtain high-resolution surface images and compare the differences before and after modification. The topological structure of the device surface and the nanoscale features of the antigen binding region were observed by AFM. The electrical performance of the modified OECT device was analyzed again using the Kickstart2 semiconductor parameter analyzer. The electrical performance test was performed by connecting the device to a computer for analysis and setting appropriate test parameters, such as voltage range, scan rate, etc.

[0117] The results show:

[0118] (1) Electron microscopic observation of the modified area of ​​the organic electrochemical transistor before and after SEA antigen modification revealed obvious contrast results, such as Figure 4 As shown. Before modification, the surface of OECT showed a typical gold nanoparticle morphology. Figure 4 (a) in the figure); after SEA antigen modification, the electron micrograph shows that the modified area has changed significantly. The modified layer successfully adheres to the OECT surface, forming a uniform and dense covering layer ( Figure 4 (b)), its morphological features have changed significantly compared to before modification, proving that SEA modification is successful.

[0119] (2) Atomic force microscopy (AFM) observation results of the modified area of ​​the organic electrochemical transistor before and after SEA antigen modification are as follows Figure 5 As shown. Before modification, the surface atomic arrangement of OECT showed relatively flat and orderly characteristics ( Figure 5 (a)), Ra = 33.8nm, Rq = 28.3nm; after SEA antigen modification of OECT, obvious morphological changes occurred on the surface ( Figure 5In (b), the atomic arrangement becomes more compact, and parameters such as surface roughness and surface roughness increase to Ra = 109nm and Rq = 86.3nm, which directly reflects the successful coverage and improvement of the SEA antigen modification layer on the OECT surface. After modification, obvious protrusions caused by the SEA antigen appear on the surface.

[0120] (3) In order to prove the stability of the OECT device, we tested the IV curves of the device before and after modification when the voltage between the source and drain electrodes was 1V and the gate voltage varied from -3V to +3V; that is, the modified OECT probe prepared in Example 2 was placed in a test fixture, and the probe was placed on the designated source, gate, and drain electrodes respectively, and the source voltage was set to 1V, the drain voltage was set to 1V, and the gate voltage was set to -3V, 2V, -1V, 0V, 1V, 2V, or 3V;

[0121] The results are as follows Figure 6 ,in Figure 6 (a) is the IV line of a single experiment. Figure 6 (b) is the average result of multiple experiments. It can be seen from the figure that the current of the modified OECT device becomes smaller than that before modification.

[0122] Example 5: Detection of SEA antibody concentration in a buffer system after surface modification of OECT device

[0123] After the surface modification of the OECT device, a series of different concentrations of SEA antibodies were used, and the known concentration of SEA antibodies was diluted to 0.001μg / mL, 0.01μg / mL, 0.1μg / mL, 1μg / mL, 10μg / mL and 100μg / mL using phosphate buffered saline (PBS) as a solvent to construct a set of concentration gradients. This step obtains different concentrations of SEA antibodies, which bind to the modified device differently, resulting in different current changes in the analyzer.

[0124] The specific steps are as follows:

[0125] (1) 10 μL of SEA antibody of each concentration gradient (0.001 μg / mL, 0.01 μg / mL, 0.1 μg / mL, 1 μg / mL, 10 μg / mL and 100 μg / mL) was added to the gate electrode of the modified OECT device prepared in Example 2 ( Figure 1 The device was placed in a modified gate (in the middle) and allowed to react at 25°C for 1 hour. This period of time is sufficient for the antibody to fully bind and interact with the modified layer on the device surface, thereby forming a stable complex.

[0126] (2) After the reaction is completed, use PBS to rinse and remove the SEA antibody that is not bound to the device surface to ensure the accuracy and reliability of the experimental results.

[0127] (3) Use Kickstart2 semiconductor analyzer to test the electrical properties of the modified device. The specific steps are: place the modified OECT device prepared in Example 2 in a test fixture, place the probes on the designated source, gate, and drain electrodes, set the source voltage to 1V, the drain voltage to 1V, and the gate voltage to -3V, 2V, -1V, 0V, 1V, 2V, or 3V; by adjusting the instrument parameters, such as voltage range, scan rate, etc., we can obtain key data such as current-voltage curves and current-time curves. These curves reflect the changes in electrical properties after different concentrations of antibodies bind to the device surface, providing quantitative analysis and evaluation of the antigen binding effect.

[0128] The results show:

[0129] (1) The SEA antibody was diluted with PBS to obtain SEA antibodies with concentrations of 0.001 μg / mL, 0.01 μg / mL, 0.1 μg / mL, 1 μg / mL, 10 μg / mL, and 100 μg / mL, respectively. The SEA antibodies were reacted with the modified OECT devices for 1 h, and the voltage between the source and the drain was adjusted to 1 V, and the gate voltage was adjusted to -3 V to +3 V. Figure 7 In (a), it can be seen that as the concentration of bound SEA antibody increases, the current gradually increases.

[0130] (2) Since the current is most stable at -3V voltage, when other conditions remain unchanged, the gate voltage is selected as -3V, and the current time variation curve is obtained as follows Figure 7 As shown in (b), the change in current over time after combination is very small and can be ignored, which further improves the stability of subsequent measurements.

[0131] (3) Take IV curves with different concentration gradients, fix the gate voltage at -3 V, and subtract the measured current from the unbound current after modification to obtain the current change. Plot it against the concentration gradient to obtain a standard curve. The results are as follows: Figure 8 As shown in the figure, the standard curve can not only detect the presence of SEA antibody by measuring the change in current, but also quantitatively detect the concentration of SEA antibody.

[0132] The content of SEA antibody in the sample was detected by the following formula: y=-0.0085x4+0.0978x3-0.3255x2+0.4524x-0.0417.

[0133] Example 6: Detection of SEA antibody concentration in serum system after surface modification of OECT device

[0134] High-quality rabbit serum was obtained from the Jiangsu Provincial Schistosoma Control Institute and used as a solvent for diluting SEA antibodies. Then, according to the predetermined ratio, the known concentration of SEA antibodies was gradually diluted with serum to six different concentration gradients: 0.001μg / mL, 0.01μg / mL, 0.1μg / mL, 1μg / mL, 10μg / mL and 100μg / mL. During the dilution process, each step of the operation was strictly controlled to ensure the accuracy of each concentration gradient.

[0135] The specific steps are as follows:

[0136] (1) The modified OECT devices prepared in Example 2 were prepared respectively, and different concentrations (0.001 μg / mL, 0.01 μg / mL, 0.1 μg / mL, 1 μg / mL, 10 μg / mL and 100 μg / mL) of anti-SEA were added to the gate electrode ( Figure 1 The device was allowed to react at 25°C for 1 h to allow sufficient time for the antibody to interact with the molecules on the device surface.

[0137] (2) After the reaction, the device was rinsed with PBS to remove unbound anti-SEA to reduce experimental errors and improve measurement accuracy.

[0138] (3) Use the Kickstart2 semiconductor analyzer to measure the current-voltage of OECT devices bound to different concentrations of antibodies. Adjust the setting parameters of the analyzer to capture the changes in weak electrical signals generated after the antibody binds to the device. By recording and analyzing these curves, the current-voltage change curves of the interaction between the antibody and the OECT device under different concentration gradients are obtained.

[0139] The results show:

[0140] The above experiments prove that the OECT device can play a good detection role in the system with PBS as solvent. In order to facilitate the detection, we replaced the PBS solvent with rabbit serum and repeated the experiment. The standard curve is shown in the figure below. Fig. 9 Compared with the PBS solvent system curve, the change in device current in serum is reduced. This may be because the serum system is more complex than the PBS system, including non-specific antibodies, fatty acids, steroids, serum proteins and other substances, which have a certain impact on the entire system. However, the overall trend remains unchanged and can be used to quantitatively measure the concentration of SEA antibodies in serum.

[0141] The content of SEA antibody in the sample was detected by the following formula: y=-0.0016x4+0.0205x3-0.0918x2+0.2061x-0.0592.

[0142] Example 7: Specificity analysis of SEA antibody detection in serum system after surface modification of OECT device

[0143] High-quality rabbit serum was obtained from the Jiangsu Provincial Schistosoma Control Institute and used as a solvent for diluting SEA antibodies. Liver fluke antibodies and lung fluke antibodies were prepared as interfering substances, and the concentrations of liver fluke and lung fluke antibodies sent by the Jiangsu Provincial Schistosoma Control Institute were measured using the White Shark BCA kit to ensure that their concentrations were equivalent to the SEA antibodies used in the experiment. These two interfering substances will be used in control experiments to verify the specific recognition ability of the OECT device for SEA antibodies. The concentrations of liver fluke antibodies and lung fluke antibodies provided by Jiangsu Provincial Schistosoma Control were 30 mg / mL and 35 mg / mL, respectively. The concentrations of schistosoma antibody solution, liver fluke antibody solution, and lung fluke antibody solution were obtained by dilution with concentrations of 0.1 μg / mL, 1 μg / mL, and 10 μg / mL, respectively.

[0144] The specific steps are as follows:

[0145] (1) Take the modified OECT device prepared in Example 2, and then select 10 μL of SEA antibody (concentrations are 0.1 μg / mL, 1 μg / mL, 10 μg / mL), liver fluke antibody (concentrations are 0.1 μg / mL, 1 μg / mL, 10 μg / mL) and lung fluke antibody (concentrations are 0.1 μg / mL, 1 μg / mL, 10 μg / mL) and add them to the gate of different modified OECT devices ( Figure 1 in the modified grid).

[0146] The device was allowed to react at 25°C for 1 hour to allow the antibody to fully interact with the molecules on the device surface.

[0147] (2) After the reaction is completed, the device is rinsed with PBS to remove unbound antibodies.

[0148] (3) Use the kickstart2 semiconductor analyzer to measure the current-voltage and current-time curves of the OECT devices combined with different antibodies. Set the source voltage to 1V, the drain voltage to 1V, and the gate voltage to -3V; record and analyze the changes in the electrical signals generated after each antibody binds to the device. By comparing the changes in electrical signals after different antibodies bind to the OECT device, analyze the specific recognition ability of the OECT device for SEA antibodies. If the electrical signal changes generated by the SEA antibody are significantly higher than those of the liver fluke antibody and the lung fluke antibody, it indicates that the OECT device has good specificity for the SEA antibody. The specific recognition results of the OECT device are then compared with the standard test strip method to verify its accuracy and reliability.

[0149] (4) Prepare commercially available SEA test strips and operate according to the instructions. Use the test strips to detect schistosome antibodies (4 mg / mL, 3 mg / mL, 2 mg / mL, 1 mg / mL, 0.1 mg / mL), liver fluke antibodies (4 mg / mL, 3 mg / mL, 2 mg / mL, 1 mg / mL, 0.1 mg / mL), and lung fluke antibodies (4 mg / mL, 3 mg / mL, 2 mg / mL, 1 mg / mL, 0.1 mg / mL). Observe the color development of the test strips at high and low concentrations. Based on the experimental results of specificity analysis and sensitivity comparison, compare the test strips with the OECT device to find the performance advantages of the OECT device in SEA antibody detection.

[0150] The results show:

[0151] (1) After measurement, when the source-drain voltage was 1V and the gate voltage was -3V, the current change of the schistosome antibody under the three concentration conditions was much higher than that of the other two antibodies, such as Fig.10 As shown, it is proved that the OECT device is specific for the detection of Schistosoma japonicum antibodies; Fig.10 Current changes of three antibodies at concentrations of (a) 0.1 μg / mL, (b) 1 μg / mL, and (c) 10 μg / mL.

[0152] (2) The specificity of the existing schistosoma detection kits on the market was analyzed. From left to right, the concentrations of the five test strips were 4 mg / mL, 3 mg / mL, 2 mg / mL, 1 mg / mL, and 0.1 mg / mL. The results showed that regardless of schistosoma antibody ( Fig.11 (a)), liver fluke antibodies ( Fig.11 (b)) or Paragonimus antibodies ( Fig.11 (c)) At concentrations above 2 mg / mL, color reaction can occur, and the three antibodies cannot be clearly distinguished, indicating no specificity; and below 2 mg / mL, it cannot be detected;

[0153] In comparison, even at very low antibody concentrations (0.1 μg / mL), the OECT device can detect significant current changes, indicating that the OECT device has high sensitivity and can meet the needs of actual detection of schistosome antibodies.

[0154] (3) The results show that:

[0155] Compared with the commercially available schistosomiasis infection detection test strips, the OECT device designed in this experiment showed extremely high sensitivity and specificity. It can detect schistosomiasis antibodies as low as 0.001μg / mL (while the commercially available ones cannot detect below 2mg / mL), and the current change is significantly higher than the antibodies that the other two test strips cannot distinguish (liver fluke and lung fluke antibodies). This feature gives the OECT device a significant advantage in the field of antibody detection, especially in rapid detection scenarios that require distinguishing different types of antibodies or detecting low-concentration antibodies.

[0156] Although the present invention has been disclosed as above in the form of a preferred embodiment, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be based on the definition of the claims.

Claims

1. An antibody sensor based on an organic electrochemical transistor, characterized in that: The antibody sensor comprises, from bottom to top, a substrate layer, an organic semiconductor layer, a solid ion gel electrolyte layer, an organic semiconductor doping layer and a gate; the organic semiconductor layer and the organic semiconductor doping layer are both P-type organic semiconductors, and the organic semiconductor doping layer is a P-type organic semiconductor doped with a P-type dopant; After the gate surface is cleaned with ethanol and deionized water, cysteamine and soluble worm egg antigen (SEA) are used as modifiers in sequence to modify the gate surface of the device to form a self-assembled molecular film.

2. The antibody sensor according to claim 1, characterized in that The substrate layer is a glass sheet of source and drain electrodes, and the solid ion gel electrolyte layer is formed by spin coating after doping ionic liquid in PVDF-HFP solution, and the ionic liquid is EMIMTFSI, EMIM BF4 or a mixture of the two.

3. The antibody sensor according to claim 1 or 2, characterized in that: The modification method of the gate self-assembled molecular film comprises: (1) Wash with deionized water and ethanol respectively and then blow dry; (2) After drying, add cysteamine to the gate and react for 6 to 8 hours in the dark. After washing and drying, add glutaraldehyde and react for 1 to 2 hours. (3) After the reaction in step (2), the grid is rinsed with water and blown dry, and soluble egg antigen SEA is added to react again for 1 to 2 hours; (4) After the reaction in step (3) is completed, the mixture is rinsed and dried, and then bovine serum albumin is added to react for 1 to 2 hours to passivate the aldehyde groups that have not reacted with SEA, followed by washing and drying.

4. The antibody sensor according to any one of claims 1 to 3, characterized in that: In step (2), the concentration of cysteamine is 0.4-0.5 mM, and the volume fraction of glutaraldehyde is 2-2.5%; in step (3), the concentration of soluble egg antigen SEA is 45-50 μg / mL; and in step (4), the mass fraction of bovine serum albumin is 1-1.5%.

5. A method for preparing an antibody sensor based on an organic electrochemical transistor according to any one of claims 1 to 4, characterized in that: The method comprises: Step 1): spin coating a layer of organic semiconductor solution on the substrate with the active and drain electrodes, and annealing to form an organic semiconductor layer; Step 2): spin coating an ionic gel electrolyte solution on the organic semiconductor layer, and heating and curing the solution to form a solid ionic gel electrolyte layer; Step 3): spin coating a mixed solution of an organic semiconductor and a dopant on the solid ion gel electrolyte layer, and annealing to form an organic semiconductor doping layer; Step 4): evaporating a gate electrode on the organic semiconductor doping layer; Step 5): After the gate surface is washed with ethanol and water, cysteamine and soluble egg antigen SEA are used as modifiers in sequence to modify the gate surface of the device to form a self-assembled molecular film.

6. The preparation method according to claim 5, characterized in that: The organic semiconductor in step 1) and the organic semiconductor in step 3) are P-type organic semiconductors; the ion gel electrolyte solution is an ionic liquid doped in a PVDF-HFP solution, and the ionic liquid is EMIM TFSI, EMIM BF4 or a mixture of the two; the dopant in step 3) is a P-type dopant; Preferably, the method for modifying the gate self-assembled molecular film comprises: (1) Wash with water and ethanol respectively and then blow dry; (2) After drying, add cysteamine to the gate and react for 6 to 8 hours in the dark. After washing and drying, add glutaraldehyde and react for 1 to 2 hours. (3) After the reaction in step (2), the grid is rinsed with water and blown dry, and soluble egg antigen SEA is added to react again for 1 to 2 hours; (4) After the reaction in step (3) is completed, the mixture is rinsed and dried, and then bovine serum albumin is added to react for 1 to 2 hours to passivate the aldehyde groups that have not reacted with SEA, followed by washing and drying.

7. A method for detecting SEA antibodies in a sample, characterized in that: The method is not intended for disease diagnosis and treatment. The method is to add a sample to the gate of an antibody sensor based on an organic electrochemical transistor as described in any one of claims 1 to 4 for reaction, and then detect whether the sample contains SEA antibodies through a current-voltage curve, and at the same time detect the content of SEA antibodies in the sample.

8. The method according to claim 7, characterized in that After adding the sample to the gate, the voltage between the source and the drain is adjusted to 1V, and the gate voltage is -3V to +3V; preferably, the gate voltage is fixed to -3V, and when the sample is a buffer solution, the content of SEA antibodies in the sample is detected by the following formula: y = -0.0085x4 + 0.0978x3 - 0.3255x2 + 0.4524x - 0.0417; Preferably, the fixed gate voltage is -3 V, and when the sample is serum, the content of SEA antibodies in the sample is detected by the following formula: y=-0.0016x4+0.0205x3-0.0918x2+0.2061x-0.0592.

9. A product, characterized in that The product contains the antibody sensor based on organic electrochemical transistor according to any one of claims 1 to 4; the product is a biochip for detecting SEA antibodies in a sample, or the product is a device for detecting SEA antibodies in a sample, or the product is a kit for detecting SEA antibodies in a sample.

10. Use of the antibody sensor according to any one of claims 1 to 4 in preparing a product for detecting SEA antibodies in a sample, characterized in that: The product is a biochip for detecting SEA antibodies in a sample, or the product is a device for detecting SEA antibodies in a sample, or the product is a kit for detecting SEA antibodies in a sample.

Citation Information

Patent Citations

  • Chicken yolk antibody-magnetic bead ELISA (Enzyme-Linked Immuno Sorbent Assay) method for detecting schistosoma japonica circulating antigen

    CN102043053A

  • Field effect transistor structure-based pH sensing device and manufacturing method thereof

    CN107505376A

  • Raman sensing analysis method for detecting enterotoxin

    CN112858255A

  • Organic electrochemical transistor based on porous semiconductor layer and preparation method thereof

    CN115666138A

  • Alkali-doped organic electrochemical transistor, dissolved oxygen sensing patch and application thereof

    CN115802766A